VERU
Veru Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Veru has 3 disclosed suppliers and 2 disclosed customers in SEC filings.
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
SentenceThe Pill Club was one of the largest customers of the FC2 Business, accounting for 44% of our net revenues in fiscal 2022 and 43% of our net revenues in fiscal 2021.
VERU 10-Kaccession 0001437749-25-038089
SentenceOn October 31, 2016, we completed our acquisition of Aspen Park Pharmaceuticals, Inc. (the "APP Acquisition"), which transitioned us from a single product company selling FC2 to a biopharmaceutical company with a robust drug development program.
VERU 10-Kaccession 0001437749-25-038089
SentenceThis license contains provisions requiring milestone and royalty payments to the licensor (Ohio State Innovation Foundation).
VERU 10-Kaccession 0001437749-25-038089
SentenceAll the nonclinical and clinical efficacy and safety data on enobosarm including those generated by these five third-party clinical trials are owned by Veru pursuant to an assignment from the University of Tennessee Research Foundation.
VERU 10-Kaccession 0001437749-25-038089
SentenceWe have only obtained regulatory approval for one drug, ENTADFI (tadalafil and finasteride) capsules, for oral use, which we sold to ONCO in April 2023.
VERU 10-Kaccession 0001437749-25-038089
Veru Inc.
2.19
Expected move
No implied move.